Vertex Pharmaceuticals VRTX34 Income Statements

Conto economico

Quarter End	Giu 2022	Set 2022	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	2,25B	2,34B	2,3B	2,37B	2,5B	2,48B	2,57B	2,69B
Reddito operativo	1,11B	1,13B	1,03B	777,1M	1,03B	1,04B	988,5M	1,14B
Reddito ante imposte	1,02B	1,18B	1,08B	891,5M	1,16B	1,18B	1,1B	1,28B
Reddito netto	810,5M	930,5M	818,9M	699,8M	915,7M	1,04B	919,6M	1,1B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	1,03B	1,18B	994,5M	778,4M	1,03B	1,02B	963,1M	1,11B
EBITDA	1,14B	1,16B	1,07B	815,9M	1,07B	1,08B	1,05B	1,19B

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	1,7B	2,49B	3,05B	4,16B	6,21B	7,58B	8,99B	9,92B
Reddito operativo	9,94M	123,24M	635,15M	1,2B	2,86B	2,78B	4,31B	3,83B
Reddito ante imposte	-67,37M	-15,69M	600,24M	1,39B	3,12B	2,73B	4,23B	4,33B
Reddito netto	-112,05M	263,48M	2,1B	1,18B	2,71B	2,34B	3,32B	3,57B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	-0.451	1.04	8.218	4.544	10.434	9.204	12.925	13.856
UTILE OPERATIVO	9,94M	41,86M	634,36M	1,26B	2,98B	2,79B	4,32B	3,79B
EBITDA	71,33M	441,93M	736,57M	1,3B	2,97B	2,91B	4,46B	4,01B